Differential effects of overexpression of ERα and ERΒ in MCF10A immortalised, non-transformed human breast epithelial cells

Hormone Molecular Biology and Clinical Investigation

Volumn 1, Issue 3, 2010, Pages 117-126

  Pugazhendhi, Dhamayanthi ^a   Darbre, Philippa D ^a  

^a UNIVERSITY OF READING   (United Kingdom)

Author keywords

breast; ER ; ER ; genistein; MCF10A cells; oestrogen; oestrogen receptor overexpression

Indexed keywords

ESTRADIOL; ESTROGEN; GENISTEIN; METHYLCELLULOSE; PHYTOESTROGEN;

ARTICLE; BREAST CELL LINE; BREAST EPITHELIUM CELL; CELL CLONE; CELL GROWTH; CELL PROLIFERATION; CELL STRUCTURE; CELL SUSPENSION; CONTROLLED STUDY; EPITHELIAL CELL LINE; GROWTH STIMULATION; HUMAN; HUMAN CELL; IMMORTALIZED CELL LINE; IMMUNOBLOTTING; MONOLAYER CULTURE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REPORTER GENE; STABLE EXPRESSION; SUSPENSION CELL CULTURE; WESTERN BLOTTING;

EID: 84875618312     PISSN: 18681883     EISSN: 18681891     Source Type: Journal    
DOI: 10.1515/HMBCI.2010.013     Document Type: Article

References (46)

1. Miller WR. Estrogen and breast cancer. London: Chapman and Hall., 1996.
2. Oettel M., Schillinger E., editors. Estrogens and antiestrogens. Handbook of experimental pharmacology. Vol. 135: I/II. Berlin: Springer-Verlag., 1999.
3. Charpentier AH., Bednarek AK., Daniel RL., Hawkins KA., Laflin KJ., Gaddis S., MacLeod MC., Aldaz CM. Effects of estrogen on global gene expression: identification of novel targets of estrogen action. Cancer Res 2000;60:5977-83.
4. Soulez M., Parker MG. Identification of novel oestrogen receptor target genes in human ZR75-1 breast cancer cells by expression profiling. J Mol Endocrinol 2001;27:259-74.
5. Inoue A., Yoshida N., Omoto Y., Oguchi S., Yamori T., Kiyama R., Hayashi S. Development of cDNA microarray for expression profiling of estrogen-responsive genes. J Mol Endocrinol 2002; 29:175-92.
6. Frasor J., Danes JM., Komm B., Chang KCN., Lyttle CR., Kat-zenellenbogen BS. Profiling of estrogen up-and down-regulated gene expression in human breast cancer cells: insights into gene networks and pathways underlying estrogenic control of proliferation and cell phenotype. Endocrinology 2003;144:4562-74.
7. Santen RJ., Lobenhofer EK., Afshari CA., Bao Y., Song RX. Adaptation of estrogen-regulated genes in long-term estradiol deprived MCF-7 breast cancer cells. Breast Cancer Res Treat 2005;94:213-23.
8. Sadler AJ., Pugazhendhi D., Darbre PD. Use of global gene expression patterns in mechanistic studies of oestrogen action in MCF7 human breast cancer cells. J Steroid Biochem Mol Biol 2009;114:21-32.
9. Hall JM., Couse JF., Korach KS. The multifaceted mechanisms of estradiol and estrogen receptor signaling. J Biol Chem 2001; 276:36869-72.
10. Marino M., Galluzzo P., Ascenzi P. Estrogen signaling multiple pathways to impact gene transcription. Curr Genomics 2006;7: 497-508.
11. Lonning PE. Endocrinology and treatment of breast cancer. Clin Endocrinol Metab 2004;18:1-130.
12. Fox EM., Davis RJ., Shupnik MA. ERb in breast cancer-onlooker., passive player., or active protector? Steroids 2008; 73:1039-51.
13. Hartman J., Strom A., Gustafsson JA. Estrogen receptor beta in breast cancer-diagnostic and therapeutic implications. Steroids 2009;74:635-41.
14. Skliris GP., Leygue E., Watson PH., Murphy LC. Estrogen receptor alpha negative breast cancer patients: estrogen receptor beta as a therapeutic target. J Steroid Biochem Mol Biol 2008;109: 1-10.
15. Green CA., Peter MB., Speirs V., Shaaban AM. The potential role of ERb isoforms in the clinical management of breast cancer. Histopathology 2008;53:374-80.
16. Jiang SY., Jordan VC. Growth regulation of estrogen receptor-negative breast cancer cells transfected with complementary DNAs for estrogen receptor. J Natl Cancer Inst 1992;84:580-91.
17. Pilat MJ., Christman JK., Brooks SC. Characterization of the estrogen receptor transfected MCF10A breast cell line 139B6. Breast Cancer Res Treat 1996;37:253-66.
18. Lazennec G., Katzenellenbogen BS. Expression of human estrogen receptor using an efficient adenoviral gene delivery system is able to restore hormone-dependent features to estrogen receptor-negative breast carcinoma cells. Mol Cell Endocrinol 1999; 149:93-105.
19. Lazennec G., Bresson D., Lucas A., Chaveau C., Vignon F. ERb inhibits proliferation and invasion of breast cancer cells. Endocrinology 2001;142:4120-30.
20. Moggs JG., Murphy TC., Lim FL., Moore DJ., Stuckey R., Antro-bus K., Kimber I., Orphanides G. Anti-proliferative effect of estrogen in breast cancer cells that re-express ERa is mediated by aberrant regulation of cell cycle genes. J Mol Endocrinol 2005;34:535-51.
21. Paruthiyil S., Parmar H., Kerekatte V., Cunha GR., Firestone GL., Leitman DC. Estrogen receptor Β inhibits human breast cancer cell proliferation and tumor formation by causing a G2 cell cycle arrest. Cancer Res 2004;64:423-8.
22. Strom A., Hartman J., Foster JS., Kietz S., Wimalasena J., Gus-tafsson JA. Estrogen receptor Β inhibits 17Β-estradiol-stimulat-ed proliferation of the breast cancer cell line T47D. Proc Natl Acad Sci USA 2004;101:1566-71.
23. Hartman J., Lindberg K., Morani A., Inzunza J., Strom A., Gis-tafsson JA. Estrogen receptor Β inhibits angiogenesis and growth of T47D breast cancer xenografts. Cancer Res 2006; 66:11207-13.
24. Omoto Y., Eguchi H., Yamamoto-Yamaguchi Y., Hayashi SI. Estrogen receptor (ER) Β1 and ERΒcx/Β2 inhibit ERa function differently in breast cancer cell line MCF7. Oncogene 2003; 22:5011-20.
25. Murphy LC., Peng B., Lewis A., Davie JR., Leygue E., Kemp A., Ung K., Vendetti M., Shiu R. Inducible upregulation of oestrogen receptor-b1 affects oestrogen and tamoxifen responsiveness in MCF7 human breast cancer cells. J Mol Endocrinol 2005;34: 553-66.
26. Behrens D., Gill JH., Fichtner I. Loss of tumourigenicity of stably ERb-transfected MCF-7 breast cancer cells. Mol Cell Endocri-nol 2007;274:19-29.
27. Tonetti DA., Rubenstein R., Deleon M., Zhao H., Pappas SG., Ben-trem DJ., Chen B., Constantinou A., Jordan VC. Stable transfec-tion of an estrogen receptor beta cDNA isoform into MDA-MB-231 breast cancer cells. J Steroid Biochem Mol Biol 2003; 87:47-55.
28. Hou YF., Yuan ST., Li HC., Wu J., Lu JS., Liu G., Lu LJ., Shen ZZ., Ding J., Shao ZM. ERΒ exerts multiple stimulative effects on human breast carcinoma cells. Oncogene 2004;23:5799-806.
29. Soule HD., Maloney TM., Wolman SR., Peterson WD., Brenz R., McGrath CM., Russo J., Pauley RJ., Jones RF., Brooks SC. Isolation and characterization of a spontaneously immortalized human breast epithelial cell line., MCF-10. Cancer Res 1990;50: 6075-86.
30. Hall JM., McDonnell DP. The estrogen receptor Β-isoform (ERΒ) of the human estrogen receptor modulates ERα transcrip-tional activity and is a key regulator of the cellular response to estrogens and antiestrogens. Endocrinology 1999;140:5566-78.
31. Southern PJ., Berg P. Transformation of mammalian cells to anti biotic resistance with a bacterial gene under control of the SV40 early region promoter. J Mol Appl Genet 1982;1:327-41.
32. Daly RJ., Darbre PD. Cellular and molecular events in loss of estrogen sensitivity in ZR-75-1 and T-47-D human breast cancer cells. Cancer Res 1990;50:5868-75.
33. Shaw LE., Sadler AJ., Pugazhendhi D., Darbre PD. Changes in oestrogen receptor-α and-Β during progression to acquired resistance to tamoxifen and fulvestrant (Faslodex., ICI 182,780) in MCF7 human breast cancer cells. J Steroid Biochem Mol Biol 2006;99:19-32.
34. Darbre P. Effect of overexpression of ERbeta on the molecular action of phytoestrogens. Final technical report T05025. Food Standards Agency London: Crown Copyright., 2007. pp. 1-80. (Executive summary of T05025 available from the Food Standards Agency Website http://www.food.gov.uk/multimedia/pdfs/ T01T05T09report (pp. 120-122).)
35. Martin MB., Saceda M., Lindsey RK. Regulation of estrogen receptor expression in breast cancer. Adv Exp Med Biol 1993; 330:143-53.
36. Woods HF., Chairman. Phytoestrogens and health. London: Crown Copyright., 2003. pp. 1-440.
37. Kuiper GG., Carlsson B., Grandien K., Enmark E., Haggblad J., Nilsson S., Gustafsson JA. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology 1997;138:863-70.
38. Kuiper GG., Lemmen JG., Carlsson B., Corton JC., Safe SH., Van der Saag PT., Van der Burg B., Gustafsson JA. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 1998;139:4252-63.
39. Matsumura A., Ghosh A., Pope GS., Darbre PD. Comparative study of oestrogenic properties of eight phytoestrogens in MCF7 human breast cancer cells. J Steroid Biochem Mol Biol 2005; 94:431-43.
40. Tait L., Soule HD., Russo J. Ultrastructural and immunocytoche-mical characterization of an immortalized human breast epithelial cell line., MCF-10. Cancer Res 1990;50:6087-94.
41. Darbre PD., King RJB. Steroid hormone regulation of cultured breast cancer cells. In: Lippman ME., Dickson RB., editors. Breast cancer: cellular and molecular biology. Boston., MA: Klu-wer Academic Publishers., 1988. pp. 307-341.
42. Russo J., Fernandez SV., Russo PA., Ferbaugh R., Sheriff FS., Lareef HM., Garber J., Russo IH. 17-Beta-estradiol induces transformation and tumorigenesis in human breast epithelial cells. FASEB J 2006;20:1622-34.
43. Masamura S., Santner SJ., Heitjan DF., Santen RJ. Estrogen deprivation causes estradiol hypersensitivity in human breast cancer cells. J Clin Endocrinol Metab 1996;80:2918-25.
44. Lewis JS., Osipo C., Meeke K., Jordan VC. Estrogen-induced apoptosis in a breast cancer model resistant to long-term estrogen withdrawal. J Steroid Biochem Mol Biol 2005;94:131-41.
45. Murphy LC., Watson PH. Is oestrogen receptor-Β a predictor of endocrine therapy responsiveness in human breast cancer? Endocr Relat Cancer 2006;13:327-34.
46. Stanisic V., Lonard DM., O'Malley BW. Estrogen receptor-α: molecular mechanisms and interactions with the ubiquitin proteasome system. Hormones Mol Biol Clin Invest 2009;1:in press.